abstract |
The present invention relates to the treatment or prevention of diseases related to the use of antibiotics or cancer chemotherapy or antiviral therapies, such as colitis, pseudomembranous colitis, associated with antibiotic diarrhea, and infections due to C. perylicus, methicillin-resistant Staphylococcus aureus (MRSA) or Enterococcus, including vancomycin-resistant Enterococci (VRE) with Compound I. |